Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.
Views & Analysis Capturing progress in haemophilia care If we look back just 70 years, the prognosis for patients with haemophilia was remarkably different to what it is today.
Patients Time for change: PhRMA survey shows insurance creates barrie... Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new PhRMA report.
Views & Analysis Closing the feedback loop to drive patient experience improv... Is collecting near real time data the key to unlocking improvements in patient experience and national benchmarking?
R&D Sponsored Vaccines trials in the COVID-19 era and tech's role in speed... Overview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus vaccine.
Digital Eyeforpharma Barcelona 2019 roundup This year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting the downfall of pharma as we know it – but there were plenty of speake
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends